BusinessCancer Genetics, Inc. to Host Panel Discussion on “The Convergence of Artificial Intelligence and Healthcare - New Developments in Precision Medicine” During the 3rd Annual Dawson James Small Cap Growth Conference on October 18thBy Nasdaq OMXOct 12, 2017, 11:30 AM UTC
BusinessTempus and the OHSU Knight Cancer Institute Collaborating on Personalized Medicine Data InitiativeBy Nasdaq OMXSep 28, 2017, 2:00 PM UTC
BusinessTempus and Cleveland Clinic Collaborate on Personalized Medicine InitiativeBy Nasdaq OMXSep 14, 2017, 2:30 PM UTC
BusinessTempus and University of California Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership for Cancer PatientsBy Nasdaq OMXAug 31, 2017, 2:00 PM UTC
BusinessTempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium for Phase II Clinical TrialBy Nasdaq OMXAug 17, 2017, 1:00 PM UTC
BusinessTempus Selected by University of Virginia As Partner for Large Granular Lymphocyte Leukemia Research ProjectBy Nasdaq OMXAug 3, 2017, 2:00 PM UTC
